An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Canagliflozin 300 mg; Drug: Sitagliptin 100 mg; Drug: Metformin Sponsor: Janssen Research & Development, LLC Not yet recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2017 Category: Research Source Type: clinical trials
An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Canagliflozin 300 mg; Drug: Sitagliptin 100 mg; Drug: Metformin Sponsor: Janssen Research & Development, LLC Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2017 Category: Research Source Type: clinical trials